{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:50:07Z","timestamp":1758441007516,"version":"3.44.0"},"reference-count":24,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2025]]},"DOI":"10.70352\/scrj.cr.25-0217","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T22:08:28Z","timestamp":1758060508000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["A Case of T1bN0 Esophageal Squamous Cell Carcinoma That Developed Recurrence 7 Years after Curative Esophagectomy"],"prefix":"10.70352","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9356-4897","authenticated-orcid":false,"given":"Shinichiro","family":"Shiomi","sequence":"first","affiliation":[{"name":"Department of Gastroenterological Surgery, Saitama Cancer Center Hospital, Kitaadachi-gun, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Saitama Cancer Center Hospital, Kitaadachi-gun, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Nozu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Saitama Cancer Center Hospital, Kitaadachi-gun, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiji","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Saitama Cancer Center Hospital, Kitaadachi-gun, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yoda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Endoscopy, Saitama Cancer Center Hospital, Kitaadachi-gun, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Motoi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saitama Cancer Center Hospital, Kitaadachi-gun, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saitama Cancer Center Hospital, Kitaadachi-gun, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sugiyama M, Morita M, Yoshida R, et al. Patterns and time of recurrence after complete resection of esophageal cancer. Surg Today 2012; 42: 752\u20138.","DOI":"10.1007\/s00595-012-0133-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Umemura A, Akiyama Y, Iwaya T, et al. Super-late pulmonary recurrence after radical esophagectomy for esophageal squamous cell carcinoma. Int J Surg Case Rep 2020; 72: 166\u201371.","DOI":"10.1016\/j.ijscr.2020.05.068"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sekiguchi K, Matsutani T, Nomura T, et al. Pulmonary metastasectomy for esophageal basaloid squamous cell carcinoma component at 66 months after esophagectomy. Surg Case Rep 2020; 6: 199.","DOI":"10.1186\/s40792-020-00957-z"},{"key":"4","unstructured":"4) Miyamoto H, Tamura T, Nishi S, et al. A case of late recurrence of esophageal cancer, 15 years after surgery. Gan To Kagaku Ryoho 2022; 49: 1570\u20132. (in Japanese)"},{"key":"5","unstructured":"5) Hayashi T, Nishimaki T, Suzuki T, et al. Three cases of lymph node recurrence after a long disease-free interval of over 5 years following curative resection for thoracic esophageal carcinoma. Acta Med Biol (Niigata) 2000; 48: 107\u201311."},{"key":"6","unstructured":"6) Ota Y, Minamide J, Takata K, et al. A case of advanced esophageal cancer that has come back eight years after combined modality therapy. Gan To Kagaku Ryoho 2009; 36: 2442\u20134. (in Japanese)"},{"key":"7","unstructured":"7) Yamamoto T, Tokunou K, Toshimitsu H, et al. A case of recurrent esophageal cancer successfully treated by combined therapies. Gan To Kagaku Ryoho 2010; 37: 2397\u20139. (in Japanese)"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nakano A, Hoshino I, Kawahira H, et al. A case of metastasis within the gastric tube from esophageal squamous cell carcinoma which developed nine years after curative esophagectomy. Nihon Rinsho Geka Gakkai Zasshi 2011; 72: 2530\u20134. (in Japanese)","DOI":"10.3919\/jjsa.72.2530"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Takahashi M, Hoshino I, Kano M, et al. A case of ovarian metastasis from esophageal squamous cell carcinoma that developed 5 years after curative esophagectomy. Nihon Rinsho Geka Gakkai Zasshi 2013; 74: 2761\u20135. (in Japanese)","DOI":"10.3919\/jjsa.74.2761"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Mori O, Tomibayashi A, Eto S, et al. A case of esophageal cancer with superior mediastinal lymph nodes recurrence developed more than 9 years after radical resection. Nihon Rinsho Geka Gakkai Zasshi 2020; 81: 54\u20139. (in Japanese)","DOI":"10.3919\/jjsa.81.54"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Rice TW, Patil DT, Blackstone EH. 8th edition AJCC\/UICC staging of esophagus and esophagogastric junction cancers: application to clinical practice. Ann Cardiothorac Surg 2017; 6: 119\u201330.","DOI":"10.21037\/acs.2017.03.14"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nakanoko T, Morita M, Nakashima Y, et al. Nationwide survey of the follow-up practices for patients with esophageal carcinoma after radical treatment: historical changes and future perspectives in Japan. Esophagus 2022; 19: 69\u201376.","DOI":"10.1007\/s10388-021-00869-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hiyoshi Y, Yoshida N, Watanabe M, et al. Late recurrence after radical resection of esophageal cancer. World J Surg 2016; 40: 913\u201320.","DOI":"10.1007\/s00268-015-3334-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zhu JF, Feng XY, Zhang XW, et al. Time distribution of recurrence risk of oesophageal squamous cell carcinoma with complete resection (R0) in a Chinese population. Eur J Cardiothorac Surg 2015; 48: 899\u2013905.","DOI":"10.1093\/ejcts\/ezv147"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wang S, Chen X, Fan J, et al. Prognostic significance of lymphovascular invasion for thoracic esophageal squamous cell carcinoma. Ann Surg Oncol 2016; 23: 4101\u20139.","DOI":"10.1245\/s10434-016-5416-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ohsawa M, Hamai Y, Emi M, et al. Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone. Surgery 2025; 178: 108863.","DOI":"10.1016\/j.surg.2024.09.019"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Huang Q, Luo K, Chen C, et al. Identification and validation of lymphovascular invasion as a prognostic and staging factor in node-negative esophageal squamous cell carcinoma. J Thorac Oncol 2016; 11: 583\u201392.","DOI":"10.1016\/j.jtho.2015.12.109"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612\u20138.","DOI":"10.1200\/JCO.2008.17.2361"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Udagawa T. Tumor dormancy of primary and secondary cancers. Acta Pathol Microbiol Scand Suppl 2008; 116: 615\u201328.","DOI":"10.1111\/j.1600-0463.2008.01077.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Endo H, Inoue M. Dormancy in cancer. Cancer Sci 2019; 110: 474\u201380.","DOI":"10.1111\/cas.13917"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Takashi S, Satoshi Y, Akihiko O, et al. Clinical impact of preoperative serum p53 antibody titers in 1487 patients with surgically treated esophageal squamous cell carcinoma: a multi-institutional study. Esophagus 2021; 18: 65\u201371.","DOI":"10.1007\/s10388-020-00761-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nakajima K, Takiguchi S, Mori M, et al. Peritherapeutic serum p53 antibody titers are predictors of survival in patients with esophageal squamous cell carcinoma undergoing neoadjuvant chemotherapy and surgery. World J Surg 2017; 41: 1566\u201374.","DOI":"10.1007\/s00268-017-3894-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) S\u00f8rensen RB, Andersen RS, Svane IM, et al. CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53. Clin Cancer Res 2009; 15: 1543\u20139.","DOI":"10.1158\/1078-0432.CCR-08-1412"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kawashima H, Takatori H, Suzuki K, et al. Tumor suppressor p53 inhibits systemic autoimmune diseases by inducing regulatory T cells. J Immunol 2013; 191: 3614\u201323.","DOI":"10.4049\/jimmunol.1300509"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0217\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T04:24:26Z","timestamp":1758342266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0217\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.25-0217","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.25-0217"}}